This Is Only A Test, Part Two: The Glamorous and Exotic World of Clinical Trials

Written By Kenny Kane

[audio mp3="https://pdcn.co/e/rss.art19.com/episodes/1554b9a4-e9f6-4c57-80f3-b12ae11c6d70.mp3?rss_browser=BAhJIgljdXJsBjoGRVQ%3D--435795d5c850773aaa4739d968bd77a1dfd6f301"][/audio] This Is Only A Test, Part Two: The Glamorous and Exotic World of Clinical Trials

Peter MacDowell is the Clinical Director of Rochester Dermatologic Surgery and former Co-Director of Clinical Trials Office at the Wilmot Cancer Institute. If that last name sounds familiar, well that’s because Peter is the brother of Andrew MacDowell, my Co-Founder, and COO here at OffScrip Media. Sibling rivalry be damned — and while we may have reinforced some established biases between upstate and downstate New York — we had a fantastic conversation down the rabbit hole of clinical trial treatment, management, and administration in the 21st century.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Kenny Kane

Kenny Kane is an entrepreneur, writer, and nonprofit innovator with 15+ years of experience leading organizations at the intersection of business, technology, and social impact. He is the CEO of Firmspace, CEO of the Testicular Cancer Foundation, and CTO/co-founder of Gryt Health.

A co-founder of Stupid Cancer, Kenny has built national awareness campaigns and scaled teams across nonprofits, health tech, and real estate. As an author, he writes about leadership, resilience, and building mission-driven organizations.

Previous

COVID-19 and Lung Cancer: Stigma, Advocacy, and the Latest Research
Next

This Is Only A Test, Part One: The Glamorous and Exotic World of Clinical Trials